Prof Andrew Spillane

Related Grants and Projects

• Participant in Centre of Research Excellence in Melanoma: Person, tumour and system-focussed knowledge to drive better outcomes in melanoma (funded by National Health and Medical Research Council)
• Participant in POSNOC (Positive Sentinel Node – a randomised trial of adjuvant therapy alone versus adjuvant therapy plus Clearance or axillary radiotherapy) (funded by National Health and Medical Research Council)
• Participant in Randomised phase III trial of adjuvant radiotherapy versus observation following breast conserving surgery and endocrine therapy in patients with molecularly characterised low-risk luminal A early breast cancer (funded by National Health and Medical Research Council)
• Participant in Testing if the addition of oestrogen lowering treatment to preoperative chemotherapy better reduces the size of large oestrogen receptor positive breast cancer (funded by National Health and Medical Research Council)